Roberta Laureana, MD

Division of Haematology, University of Tor Vergata
Rome, Italy

N/A

Presentation(s):

• (1498877) XPO1 mutations identify early stage CLL characterized by shorter time to first treatment and enhanced BCR signaling

  Friday, October 6, 2023
  11:35 AM – 11:40 AM EDT

• (1553031) Constituitive VLA-4 activation is linked to BCR autonomous signaling in circulating CLL cells and promotes pro-survival signals through soluble blood-borne VCAM-1 binding

  Saturday, October 7, 2023
  3:05 PM – 3:15 PM EDT